Search Within

Jaclyn Frances Hechtman

  1. "2019"
Formats
  1. Journal Article (23)
  2. Meeting Abstract (19)
  3. Review (3)
  4. Guidelines (1)
  5. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (37)
  2. Department of Medicine (36)
  3. Solid Tumor Oncology Division (36)
  4. GSK Faculty (30)
  5. Center for Pancreatic Cancer Research (28)
  6. Gastrointestinal Oncology Service (28)

More Groups

People
  1. Jinru Shia (20)
  2. David Solit (15)
  3. Michael Berger (15)
  4. Zsofia Stadler (14)
  5. Marc Ladanyi (13)
  6. Nikolaus Schultz (13)

More People

Years
  1. 2019 (47)
Publications
  1. Modern Pathology (7)
  2. Cancer Research (5)
  3. JCO Precision Oncology (5)
  4. Journal of Clinical Oncology (5)
  5. Laboratory Investigation (5)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. American Association for Cancer Research (11)
  2. American Society of Clinical Oncology (10)
  3. Nature Research (7)
  4. Nature Publishing Group (6)
  5. Oxford University Press (4)
  6. Elsevier Inc. (2)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The past, present, and future of HER2 (ERBB2) in cancer: Approaches to molecular testing and an evolving role in targeted therapy
    Review

    Hechtman, J. F.; Ross, D. S.
    Cancer Cytopathology (2019)

    Fulltext@MSK | Save
  • Efficacy of combined VEGFR1-3, PDGFα/β, and FGFR1-3 blockade using nintedanib for esophagogastric cancer
    Journal Article

    Won, E.; Basunia, A.; Chatila, W. K.; Hechtman, J. F.; Chou, J. F.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Detection of NTRK fusions: Merits and limitations of current diagnostic platforms
    Review

    Solomon, J. P.; Hechtman, J. F.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Larotrectinib demonstrates CNS efficacy in TRK fusion-positive solid tumors
    Journal Article

    Rosen, E. Y.; Schram, A. M.; Young, R. J.; Schreyer, M. W.; Hechtman, J. F.; Shu, C. A.; Ku, N. C.; Hyman, D. M.; Drilon, A.
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response
    Journal Article

    Mandal, R.; Samstein, R. M.; Lee, K. W.; Havel, J. J.; Wang, H.; Krishna, C.; Sabio, E. Y.; Makarov, V.; Kuo, F.; Blecua, P.; more...
    Science (2019)

    Fulltext@MSK | Save
  • Majority of B2M-mutant and -deficient colorectal carcinomas achieve clinical benefit from immune checkpoint inhibitor therapy and are microsatellite instability-high
    Journal Article

    Middha, S.; Yaeger, R.; Shia, J.; Stadler, Z. K.; King, S.; Guercio, S.; Paroder, V.; Bates, D. D. B.; Rana, S.; Diaz, L. A. Jr; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade
    Journal Article

    Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Vargas, H. A.; Rathkopf, D.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Prospective genotyping of hepatocellular carcinoma: Clinical implications of next-generation sequencing for matching patients to targeted and immune therapies
    Journal Article

    Harding, J. J.; Nandakumar, S.; Armenia, J.; Khalil, D. N.; Albano, M.; Ly, M.; Shia, J.; Hechtman, J. F.; Kundra, R.; El Dika, I.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
    Journal Article

    Mondaca, S.; Margolis, M.; Sanchez-Vega, F.; Jonsson, P.; Riches, J. C.; Ku, G. Y.; Hechtman, J. F.; Tuvy, Y.; Berger, M. F.; Shah, M. A.; more...
    Gastric Cancer (2019)

    Fulltext@MSK | Save
  • FOLFCIS treatment and genomic correlates of response in advanced anal squamous cell cancer
    Journal Article

    Mondaca, S.; Chatila, W. K.; Bates, D.; Hechtman, J. F.; Cercek, A.; Segal, N. H.; Stadler, Z. K.; Varghese, A. M.; Kundra, R.; Capanu, M.; more...
    Clinical Colorectal Cancer (2019)

    Fulltext@MSK | Save